Zucomet PG 1mg/500mg/15mg Tablet SR
Marketer
Zuciya Lifesciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Zucomet PG 1mg/500mg/15mg Tablet SR
Diabetic patients with type 2 mellitus may find blood glucose management improved with Glyciphage PG 1mg/500mg/15mg SR tablets, a triple-combination medication. Used alongside dietary changes and exercise, this formulation enhances insulin effectiveness, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen; taking it with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Excessive intake can cause hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse reactions encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function assessments are standard pre-treatment protocol. Limit alcohol consumption to mitigate potential side effects.
Uses of Zucomet PG 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Zucomet PG 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Zucomet PG 1mg/500mg/15mg Extended-Release Tablets should be taken with meals.
Common Side effects of Zucomet PG 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Zucomet PG 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Zucomet PG 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Zucomet PG 1mg/500mg/15mg Tablet SR works:
Zucomet PG 1mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct modes of action. This triple combination improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Zucomet PG 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Zucomet PG 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Zucomet PG 1mg/500mg/15mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Zucomet PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Zucomet PG 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Zucomet PG 1mg/500mg/15mg Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Zucomet PG 1mg/500mg/15mg Tablet SR :
Should you forget to take a Zucomet PG 1mg/500mg/15mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zucomet PG 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently